| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000011558 |
| Receipt No. | R000013522 |
| Official scientific title of the study | Study of urinary biomarker for acute renal failure . And low dose atrial natriuretic peptide provides effective renal protection from acute kidney injury after thoracic aortic surgery: a randomised controlled trial |
| Date of disclosure of the study information | 2013/08/22 |
| Last modified on | 2016/09/07 (Ver. 11) |
| Basic information | ||
| Official scientific title of the study | Study of urinary biomarker for acute renal failure . And low dose atrial natriuretic peptide provides effective renal protection from acute kidney injury after thoracic aortic surgery: a randomised controlled trial | |
| Title of the study (Brief title) | Kawasaki biomarkers trial | |
| Region |
|
|
| Condition | ||||||
| Condition | thoracic aortic aneurysm
acute kidney injury |
|||||
| Classification by specialty |
|
|||||
| Classification by malignancy | Others | |||||
| Genomic information | NO | |||||
| Objectives | |
| Narrative objectives1 | Acute kidney injury (AKI) after surgery is associated with an increased risk of
adverse events and death. Atrial natriuretic peptide (ANP) dilates the pre-glomerular renal artery and inhibits the renin-angiotensin axis. A low dose ANP infusion increases glomerular filtration rate after cardiovascular surgery,but it is not known whether it reduces the incidence of AKI or the mortality rate.To evaluate whether an intravenous ANP infusion prevents AKI in patients undergoing thoracic aortic surgery. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | the primary outcomes is the incidence of AKI within 48 hours after surgery.(serum creatinine,L-FABP,NGAL) |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | administration of ANP(0.0125microgram kg-1 min-1)
the infusion is started after induction of anesthesia and continued for 24 hours after surgery |
|
| Interventions/Control_2 | administration of 5% glucose | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)thoracic aortic surgery
2)left heart bypass and cardiopulmonary bypass 3)preoperative serum creatinine1.5mg/dL or less 4)left femoral artery or escending aorta and left pulmonary vein |
|||
| Key exclusion criteria | 1)case of deep hypothermic circulatory arrest
2)the arterial or venous cannulation sites were modified |
|||
| Target sample size | 70 | |||
| Research contact person | |
| Name of lead principal investigator | Takaaki Kamada |
| Organization | Kawasaki Saiwai Hospital |
| Division name | Department of anesthesia |
| Address | 31-27 Omiya, Saiwai, Kawasaki, Kanagawa, Japan |
| TEL | 044-544-4611 |
| tkamada0117@nifty.com | |
| Public contact | |
| Name of contact person | Takaaki Kamada |
| Organization | Kawasaki Saiwai Hospital |
| Division name | Department of anesthesia |
| Address | 31-27 Omiya, Saiwai, Kawasaki, Kanagawa, Japan |
| TEL | 044-544-4611 |
| Homepage URL | |
| tkamada0117@nifty.com | |
| Sponsor | |
| Institute | Kawasaki Saiwai Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Anesthesiology, School of Medicine, Toho University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000013522 |